US Patent 7576062 Compounds with growth hormone releasing properties

Patent 7576062 was granted and assigned to Novo Nordisk on August, 2009 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

August 18, 2009

Patent Application Number

11147017

Date Filed

June 7, 2005

Patent Primary Examiner

Patent abstract

Disclosed are compounds of formula I

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7576062 Compounds with growth hormone releasing properties

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.